CN106591240A - Hybridoma cell strain 4F4 and antibody thereof - Google Patents
Hybridoma cell strain 4F4 and antibody thereof Download PDFInfo
- Publication number
- CN106591240A CN106591240A CN201710028876.0A CN201710028876A CN106591240A CN 106591240 A CN106591240 A CN 106591240A CN 201710028876 A CN201710028876 A CN 201710028876A CN 106591240 A CN106591240 A CN 106591240A
- Authority
- CN
- China
- Prior art keywords
- cell strain
- hybridoma cell
- monoclonal antibody
- elisa
- keto acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention relates to a hybridoma cell strain 4F4 and an antibody thereof. The hybridoma cell strain 4F4 is preserved in China Center for Type Culture Collection on Dec. 27, 2016 with the preservation number of CCTCC NO:C201702. The hybridoma cell strain 4F4 generates an anti-tenuazonic acid monoclonal antibody, specifically detects tenuazonic acid, and is of great significance to detect the tenuazonic acid.
Description
Technical field
The invention belongs to biological technical field, and in particular to hybridoma cell strain 4F4, further relate to by the hybridoma cell strain
The antibody that 4F4 is produced.
Background technology
Thin Alternaria alternata bacterium keto acid (Tenuazonic acid, TA) be that rod method is mould, rice blast is mould, Sorghum vulgare Pers. point is mould etc.
One of toxic metabolic products produced under specified conditions, are after alternariol (Alternariol, AOH), alternariol monomethyl ether
A kind of rod method syphilis element that (Alternariol monomethyl ether, AME) has found afterwards.TA has acute toxicity, Asia
Acute toxicity, potential carcinogenecity, cytotoxicity, cause mammal dizziness, sialorrhea, vomiting heart beating occur then and overrun, eat
Road and the intestines and stomach large-area hemorrhage and circulatory failure, death.As TA has various biological characteristic, and in being rod method syphilis element
The maximum one kind of toxicity, studies have reported that TA can cooperate with enhancing other mycotoxins, with huge potential hazard, in recent years
Increasingly cause each side's concern and study.
TA synthesizing artificial antigens and polyclonal antibody prepare existing part and report that such as Jiang Tao etc. utilizes carbodlimide method
TA structures are modified, is coupled with bovine serum albumin and is prepared artificial antigen;Ma Liang etc. carries out derivative drawing using oximate method to TA
Enter to be coupled arm, be coupled with bovine serum albumin and hemocyanin, conjugate immunity BALB/c mouse prepares polyclonal antibody;Yang Xingxing
Deng being derived to TA using hydrazine hydrate and glyoxalic acid successively, synthesizing nitrogen-containing hetero conjugated double bond is coupled arm, enters with bovine serum albumin
Row coupling obtains complete antigen, prepares the polyclonal antibody of specific recognition TA derivant by immune new zealand white rabbit, and
Set up ELISA detection method.
Polyclonal antibody preparation time is short, preparation cost is low, but poorer than monoclonal antibody in terms of specificity, different batches
There is difference and the immunoreation of different animals between.Monoclonal antibody specificity is high, once target cell strain is screened, it is theoretical
On can just produce on all four antibody, and the consistent antibody of substantial amounts of performance can be obtained by continuous culture method, be produced
The differences between batches of product are little.The current preparation with regard to TA monoclonal antibodies and products thereof exploitation is currently in blank stage, there is no and appoints
What is reported.
The content of the invention
In view of this, an object of the present invention is to provide a kind of hybridoma cell strain 4F4;The second object of the present invention
It is the preparation method that hybridoma cell strain 4F4 is provided;The third object of the present invention is to provide to be produced by hybridoma cell strain 4F4
Raw monoclonal antibody;The fourth object of the present invention is the preparation method for providing said monoclonal antibody;The purpose of the present invention
Five be provide monoclonal antibody application.
To reach above-mentioned purpose, the present invention provides following technical scheme:
The biological deposits numbering of the 1st, hybridoma cell strain 4F4, the hybridoma cell strain 4F4 is CCTCC NO:
C201702。
2nd, the preparation method of the hybridoma cell strain 4F4, TAO couplings hemocyanin immunogen is mixed with Freund adjuvant
Immune mouse, then takes potency more than 1:The splenocyte of 10000 immune mouse is merged with myeloma cell SP2/0, is melted
ELISA detections are carried out after cultivating 10 days after conjunction, Jing screening sub-clones obtain hybridoma.
Preferably, splenocyte described in fusion and myeloma cell SP2/0 quantity ratio are 1:20.
3rd, the monoclonal antibody produced by hybridoma cell strain 4F4, the biological deposits numbering of the hybridoma cell strain 4F4
For CCTCC NO:C201702.
Hybridoma cell strain 4F4 is prepared ascites, then carries out ProteinA by the 4th, preparation method of the monoclonal antibody
Purification, obtains monoclonal antibody.
5th, application of the monoclonal antibody in the reagent for preparing detection TAO antigens.
Preferably, the monoclonal antibody is in the reagent for preparing the thin Alternaria alternata bacterium keto acid of elisa competition laws detection
Using.
Preferably, the monoclonal antibody is in the reagent for preparing the thin Alternaria alternata bacterium keto acid of elisa indirect methods detection
Using.
The beneficial effects of the present invention is:Hybridoma cell strain 4F4, the hybridoma cell strain are exempted from by TAO-KLH immunogens
Then the splenocyte of immune mouse is merged by epidemic disease mice with myeloma cell SP2/0, with TAO-BSA as antigen or chain
The thin Alternaria alternata bacterium keto acid of the mould generation of lattice spore does the monoclonal antibody that competition antigen selection detection hybridoma is produced, screening
Obtain the hybridoma that antibody titer is high, specificity is good;The cell can secrete anti-TAO-KLH monoclonal antibodies, Neng Gouyong
In detection TAO antigens, significant is detected to thin Alternaria alternata bacterium keto acid.
Description of the drawings
In order that the purpose of the present invention, technical scheme and beneficial effect are clearer, the present invention provides drawings described below and carries out
Explanation:
Fig. 1 is purifying protein SDS-PAGE electrophoresis result figures.
Biomaterial preservation
In the present invention, hybridoma cell strain 4F4 send China typical culture collection center preservation, and deposit number is CCTCC
NO:C201702, address are located at Wuhan, China Wuhan University, and preservation date is on December 27th, 2016, and Classification And Nomenclature is hybridoma
Cell strain 4F4.
Specific embodiment
Below in conjunction with accompanying drawing, the preferred embodiments of the present invention are described in detail.
Reagent and consumptive material used in the present invention is as follows:Protein Marker (bronze object is biological), Balb/c mices (are purchased from
Yangzhou University), Acr, Bis, Tris (are purchased from Sigma companies), and SDS (is purchased from Amresco companies), and TEMED (is purchased from BIO-RAD
Company), 0.22 μm of sterile filters and bag filter (are purchased from Millipore companies), and DMEM in high glucose culture medium is (public purchased from Gibco
Department), cell counting count board (is purchased from Improved Neubauer), and liquid paraffin (bronze object is biological), PEG (are purchased from sigama), and 96 is thin
Born of the same parents' culture plate (is purchased from Costar), and other reagents are domestic pure analysis pure.
Embodiment 1, animal immune and exempt from rear mice serum bioactivity
5 6~8 week old female BAl BIcs/c mices are chosen, hapten TAO is coupled into hemocyanin (Keyhole Limpet
Hemocyanin, KLH) TAO-KLH immunogens and Freund adjuvant mixed immunity, 100 μ g of subcutaneous injection, 2-3 week booster immunization
Once (first time immune original mixes with Freund's complete adjuvant, thereafter plus exempt to mix with incomplete Freund's adjuvant).Wherein, half
Antigen TAO draws after carrying out deriving to thin Alternaria alternata bacterium keto acid (Tenuaconic acid, TA) by half hydrochlorate of carboxymethyl azanol
Enter linking arm and obtain.
Four exempt from after blood sampling detection, determine that antiserum detects former potency, inspection for TAO-BSA by indirect ELISA method
Survey condition:
Envelope antigen:TAO-BSA detections are former, the thin Alternaria alternata bacterium keto acid (competition antigen) of the mould generation of rod method;Coating
Concentration:5 μ g/mL, 100 μ l/ holes;Coating buffer:(PBS, pH are 7.4) for phosphate buffer;Two resist:Mountain sheep anti mouse-HRP, 1/
5000, testing result is as shown in table 1.
Table 1, antiserum and TAO-BSA Elisa results
Initial dilution:1:500
As a result show, 5 mice ELISA potency are all higher than 1:10000, can continue to arrange Mus serum and the mould product of rod method
The competitive ELISA detection of raw thin Alternaria alternata bacterium keto acid, as a result as shown in table 2.
Table 2, antiserum and the thin Alternaria alternata bacterium keto acid competition Elisa results of the mould generation of rod method
Note:The thin Alternaria alternata bacterium keto acid initial dilution of the mould generation of rod method:100ug is initial, 3 times of dilutions
As a result show, substantially, final choice 1# mice carries out cell fusion experiment to 1#, 2#, 5# mice competition performance.
Embodiment 2, cell fusion
1st, prepared by myeloma cell
Fusion the last week, use the culture medium amplification culture SP2/0 cells of DMEM containing 10%FBS.When fusion, cell is covered with
About 6 bottles of T25 Tissue Culture Flasks, collected SP2/0 cells in 50mL centrifuge tubes on the fusion same day, and 1000rpm is centrifuged 5min.Abandon
Supernatant, then adds 20mL DMEM basal mediums, dispels cell and then counts.
2nd, prepared by splenocyte
Four Post-immunisation serum ELISA potency are 1:More than 10000 mice, exempts from for 3 days before fusion eventually, and lumbar injection resists
100 μ g of original.Merge the same day with cervical dislocation euthanasia mice to be merged.Spleen is taken with 75% alcohol-pickled 5min. is aseptic,
Spleen is put in the interior culture dish for there are 10mL DMEM bases to cultivate.Take screen cloth to be put in another plate, spleen is transferred to
On screen cloth, spleen is ground with syringe heart.Add DMEM on screen cloth, rinse screen cloth, splenocyte is more collected flat
In ware.Cell being moved in 10mL centrifuge tubes, splenocyte being washed twice with the DMEM without serum, 1000rpm centrifugation 5min are collected
Splenocyte is counted.
3rd, cell fusion
Mixing myeloma cell and splenocyte, makes myeloma cell with splenocyte quantity ratio 1:20 are advisable.Cell is put
To in 50mL centrifuge tubes, diluted with DMEM basal mediums, then 1000rpm centrifugations 5min, abandon supernatant, shake centrifuge tube makes carefully
Born of the same parents are uniform.It is slowly added to 0.8mL 50%PEG, reacts 90 seconds, be subsequently adding 20-30mL DMEM culture medium and terminate PEG, melts
The cell of conjunction is reacted 10 minutes in being put into 37 DEG C of water-baths, 1000rpm centrifugation 5min, is abandoned supernatant and is subsequently adding HAT DMEM cultures
Base.The cell of fusion is taped against in 96 orifice plates, per 100 μ L of hole, Tissue Culture Plate CO is put into into then2Cultivate in incubator.Melt
Check within 4 days after conjunction, hybridoma cell clone rate there are a small amount of cell debriss more than 50%, and cell growth state is good, fusion
ELISA selective mechanisms are proceeded by after 10 days.Testing conditions:Envelope antigen:TAO-BSA detections are former, the mould generation of rod method thin
Alternaria alternata bacterium keto acid (competition antigen);Coating concentration:5 μ g/mL, 100 μ l/ holes;Coating buffer:Phosphate buffer
(PBS,pH 7.4);Two resist:Mountain sheep anti mouse-HRP, 1/5000, as a result as shown in Table 3 and Table 4.
Cell conditioned medium and TAO-BSA Elisa results after table 3, fusion
1. number plate
2. number plate
3. number plate
4. number plate
5. number plate
6. number plate
The thin Alternaria alternata bacterium keto acid Elisa results of cell conditioned medium and the mould generation of rod method after table 4, fusion
Cell strain title | 1A2 | 1A5 | 1B5 | 1C4 | 1C8 | 1D4 | 1E1 | 1E2 | 1E4 |
OD values | 3.102 | 2.0833 | 1.807 | 0.248 | 2.549 | 0.260 | 0.235 | 0.266 | 0.279 |
Cell strain title | 1E6 | 1F10 | 1F11 | 1G10 | 1G12 | 1H9 | 1H12 | 2A4 | 2A4 |
OD values | 0.221 | 0.258 | 0.256 | 0.323 | 0.222 | 0.429 | 3.407 | 0.181 | 2.037 |
Cell strain title | 2B5 | 2C8 | 2D4 | 2D11 | 2F2 | 2F11 | 2G11 | 2H11 | 3A4 |
OD values | 0.191 | 0.283 | 0.251 | 0.248 | 0.221 | 0.219 | 0.232 | 0.228 | 1.499 |
Cell strain title | 3A12 | 3B6 | 3F3 | 3F11 | 3G8 | 3H1 | 3H5 | 4A4 | 4A5 |
OD values | 0.863 | 0.179 | 3.085 | 3.152 | 0.172 | 0.244 | 0.233 | 0.204 | 0.387 |
Cell strain title | 4A6 | 4B9 | 4B10 | 4D4 | 4E4 | 4F8 | 5C10 | 5E3 | 5E7 |
OD values | 0.264 | 3.527 | 0.189 | 1.412 | 0.252 | 0.253 | 0.540 | 0.662 | 0.170 |
Cell strain title | 5G10 | 5H2 | 6C4 | 6C9 | 6E3 | 6H6 | Positive control | Competition hole | Negative control |
OD values | 1.631 | 1.988 | 0.175 | 2.929 | 0.340 | 0.252 | 3.129 | 0.617 | 0.101 |
Embodiment 3, fusion screening and sub-clone
1st, fusion screening
In the previous day of detection, 5 μ g/mL antigens are coated with elisa plate with PBS, overnight, next day draws 100 μ of cell conditioned medium
L/ holes carry out ELISA detections according to ELISA results, judge that (sample well OD values/negative hole OD value >=2.1 item are judged in positive hole
Positive hole.The positive hole that inspection imposite is detected is chosen with single track pipettor, second confirmation detection is carried out, is further confirmed that the positive
Hole, it is determined that after positive hole cell carry out sub-clone.
2nd, sub-clone
Cell in the positive hole of piping and druming, counts, and adds N/4mL DMEM culture medium, take 100 μ l cell suspension in centrifuge tube
To in centrifuge tube, blow it is even after stay 1mL, add DMEM to 4mL, blow even, stay 100 μ l (about 2 drop) in ttom of pipe.Add in centrifuge tube
DMEM to 5mL, drops to the first three rows of 96 orifice plates after mixing, stay 1.8~2ml or so per one dropper bottom of hole, add DMEM extremely
5mL, blow it is even after drop to tri- row of D, E, F of 96 orifice plates, drip per hole one, ttom of pipe stays 1.5~1.8m or so, adds DMEM to 2.8
~3mL or so, blow it is even after drop to G, H row of 96 orifice plates, drip per hole one, examine under a microscope after 7-10 days, detection has gram
The hole of grand growth, marks monoclonal hole, and the positive monoclonal cell of picking as far as possible carries out sub-clone again, detect to
After 100% positive, choose monoclonal hole amplification culture singling.Choosing 10 plants of positive and competitive fusion cell lines carries out Ya Ke
Grand, Jing after ELISA screenings, fixed 10 plants of results are as follows:
Envelope antigen:TAO-BSA detections are former, the thin Alternaria alternata bacterium keto acid (competition antigen) of the mould generation of rod method;Coating
Concentration:5 μ g/mL, 100 μ L/ holes;Coating buffer:(PBS, pH are 7.4) for phosphate buffer;Two resist:Mountain sheep anti mouse-HRP, 1/
5000, as a result as shown in table 5.
Cell conditioned medium Elisa results after table 5, singling
Cell strain title | Indirect ELISA-OD is worth | Competitive ELISA-OD is worth |
3B3 | 2.924 | 0.712 |
3B4 | 2.950 | 0.752 |
3D12 | 2.950 | 1.079 |
4A1 | 2.899 | 0.895 |
4B9 | 2.876 | 0.883 |
4D5 | 3.236 | 0.846 |
4F4 | 3.345 | 0.231 |
4G1 | 3.412 | 1.383 |
7F11 | 3.412 | 0.524 |
7G11 | 3.236 | 0.450 |
According to the above results, 4F4 cell strains are selected to prepare ascites, because the cell strain competition performance is preferably, growing way is most fast.
Hybridoma cell strain 4F4 send China typical culture collection center preservation, and deposit number is CCTCC NO:C201702, address bit
In Wuhan, China Wuhan University, preservation date is on December 27th, 2016, and Classification And Nomenclature is hybridoma cell strain 4F4.
Embodiment 4, ProteinA antibody purifications and identification
By TAO-KLH 4F4 ascites, ProteinA purification is carried out.Protein A sepharose medium is taken, chromatographic column is loaded, by abdomen
Water presses 1 with PBS:After 1 mixing, slow loading, uses glycine elution buffer solution elution after antibodies, that is, obtains required purification
Antibody, carries out 4 DEG C of dialysed overnights immediately in PBS, the next day carry out purity, concentration and bioactivity.
Antibody indirect, competitive ELISA bioactivity, concrete operations are as follows:
(1) coating plate is designed according to experiment needs, and mark on lath;
(2) it is coated with:TAO-BSA detection antigens are diluted by 5 μ g/mL with PBS coating buffers, in adding lath after mixing, often
100 μ L of hole, 4 DEG C of refrigerator overnights;
(3) envelope antigen:TAO-BSA detects antigen;
(4) it is coated with concentration:Dilute by 5 μ g/mL, 100 μ L/ holes;
(5) it is coated with buffer:(PBS, pH are 7.4) for phosphate buffer;
(6) close:After coating is good, coating buffer is discarded, board-washing 3 times adds 200 μ l confining liquids (PBST+1%BSA) per hole,
37 DEG C of calorstat 1h, take out ELISA Plate, discard interior liquid, board-washing 1 time;
(7) one anti-reflective should:
Indirect ELISA:Antibody purification is diluted by 1/500,2 times, 37 DEG C of calorstat 1h;
Competitive ELISA:The thin 0.1 μ g/mL of Alternaria alternata bacterium keto acid of the mould generation of rod method are initial, 2 times of dilutions, per 50 μ of hole
L, synchronous to add antibody purification, antibody purification is by 1/1000 dilution, every 50 μ L of hole, 37 DEG C of calorstat 1h;
(8) two anti-reflective should
ELISA Plate is taken out, interior liquid, board-washing 3 times, in every hole, add 100 μ L to dilute ELIAS secondary antibody, enzyme mark two is discarded
It is anti-:Mountain sheep anti mouse-HRP, 1/5000,37 DEG C of calorstat 1 hour.
(9) develop the color
ELISA Plate is taken out, interior liquid is discarded, board-washing 4 times is initially charged 100 μ L TMB nitrite ions per hole, according to the depth of color
Decision developing time, general 37 DEG C, 15min.
(10) terminating reaction
100 μ L 1M HCL solution, terminating reaction are added to be engraved in 450nm readings in microplate reader, OD values are more than per hole
The corresponding dilution factor in hole of 2.1 times of the negative control OD value of setting, it is determined as the potency of the sample.
As a result as shown in table 6 and table 7.
The indirect Elisa results of table 6,4F4 antibody purifications
Note:Initial dilution:1:500;Potency is sample OD/ blank OD>=2.1 highest dilution
Drawn by testing result, the antibody titer of two concentration of 4F4 is all in 512K or so.
Table 7,4F4 antibody purifications competition Elisa results
Antibody concentration testing result shows that purified antibodies concentration is 0.4mg/mL or 0.31mg/mL;Correspondence antibody volume
For 4.0mL or 6.0mL, its purity is then detected, as a result as shown in Figure 1.As a result show, present invention antibody purity after purification
Height, can be used to detect correspondence antigen.
Finally illustrate, preferred embodiment above is only unrestricted to illustrate technical scheme, although logical
Cross above preferred embodiment to be described in detail the present invention, it is to be understood by those skilled in the art that can be
Various changes are made to which in form and in details, without departing from claims of the present invention limited range.
Claims (8)
1. hybridoma cell strain 4F4, it is characterised in that:The biological deposits numbering of the hybridoma cell strain 4F4 is CCTCC NO:
C201702。
2. the preparation method of hybridoma cell strain 4F4 described in claim 1, it is characterised in that:Hapten TAO is coupled into blood indigo plant egg
White immunogen and Freund adjuvant mixed immunity mice, then take potency more than 1:The splenocyte and bone marrow of 10000 immune mouse
Oncocyte SP2/0 is merged, and carries out ELISA detections after fusion after cultivating 10 days, and Jing screening sub-clones obtain hybridoma;
The hapten TAO introduces linking arm after carrying out deriving to thin Alternaria alternata bacterium keto acid by half hydrochlorate of carboxymethyl azanol and obtains.
3. preparation method according to claim 2, it is characterised in that:Splenocyte described in fusion and myeloma cell SP2/
0 quantity ratio is 1:20.
4. the monoclonal antibody for being produced by hybridoma cell strain 4F4, it is characterised in that:The biology of the hybridoma cell strain 4F4
Deposit number is CCTCC NO:C201702.
5. the preparation method of monoclonal antibody described in claim 4, it is characterised in that:Hybridoma cell strain 4F4 is prepared into ascites,
Then ProteinA purification is carried out, monoclonal antibody is obtained.
6. application of the monoclonal antibody described in claim 4 in the reagent for preparing the thin Alternaria alternata bacterium keto acid of detection.
7. application according to claim 6, it is characterised in that:The monoclonal antibody is preparing the detection of elisa competition laws
Application in the reagent of thin Alternaria alternata bacterium keto acid.
8. application according to claim 6, it is characterised in that:The monoclonal antibody is preparing the detection of elisa indirect methods
Application in the reagent of thin Alternaria alternata bacterium keto acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710028876.0A CN106591240B (en) | 2017-01-16 | 2017-01-16 | Hybridoma cell strain 4F4 and its antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710028876.0A CN106591240B (en) | 2017-01-16 | 2017-01-16 | Hybridoma cell strain 4F4 and its antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106591240A true CN106591240A (en) | 2017-04-26 |
CN106591240B CN106591240B (en) | 2019-05-24 |
Family
ID=58584843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710028876.0A Active CN106591240B (en) | 2017-01-16 | 2017-01-16 | Hybridoma cell strain 4F4 and its antibody |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106591240B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107255716A (en) * | 2017-06-22 | 2017-10-17 | 华南农业大学 | The monoclonal antibody and its enzyme-linked immune detection method of a kind of tenuazonic acid |
CN110470831A (en) * | 2019-07-09 | 2019-11-19 | 华南农业大学 | A kind of chemiluminescence immune analysis method and kit directly detecting tenuazonic acid based on hunchbacked source antibody |
CN110804092A (en) * | 2019-11-25 | 2020-02-18 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtA8 thereof |
CN110804094A (en) * | 2019-12-03 | 2020-02-18 | 浙江中医药大学 | Monoclonal antibody for identifying alternaria tenuis and hybridoma cell strain AtD2 thereof |
CN110862452A (en) * | 2019-11-15 | 2020-03-06 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaA1 thereof |
CN110862970A (en) * | 2019-12-05 | 2020-03-06 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtG7 thereof |
CN110894232A (en) * | 2019-11-19 | 2020-03-20 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtA1 thereof |
CN110894234A (en) * | 2019-11-29 | 2020-03-20 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaC5 thereof |
CN110894233A (en) * | 2019-11-19 | 2020-03-20 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaC2 thereof |
CN110922479A (en) * | 2019-12-10 | 2020-03-27 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtH9 thereof |
CN112285354A (en) * | 2020-11-13 | 2021-01-29 | 福建农林大学 | Gold nanoflower rapid detection test paper for detecting alternaria tenuifolia keto acid based on monoclonal antibody |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102516148A (en) * | 2011-11-23 | 2012-06-27 | 华南农业大学 | Half antigen and antigen of tenuazonic acid and preparation method and application thereof |
CN103487575A (en) * | 2013-09-02 | 2014-01-01 | 华南农业大学 | Chemiluminescent enzyme-linked immunosorbent assay kit of tenuazonic acid and application method thereof |
CN105503689A (en) * | 2015-12-17 | 2016-04-20 | 西南大学 | Alternarin tenuazonic acid artificial antigen, polyclonal antibody, preparation method and application |
-
2017
- 2017-01-16 CN CN201710028876.0A patent/CN106591240B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102516148A (en) * | 2011-11-23 | 2012-06-27 | 华南农业大学 | Half antigen and antigen of tenuazonic acid and preparation method and application thereof |
CN103487575A (en) * | 2013-09-02 | 2014-01-01 | 华南农业大学 | Chemiluminescent enzyme-linked immunosorbent assay kit of tenuazonic acid and application method thereof |
CN105503689A (en) * | 2015-12-17 | 2016-04-20 | 西南大学 | Alternarin tenuazonic acid artificial antigen, polyclonal antibody, preparation method and application |
Non-Patent Citations (1)
Title |
---|
王雅丽等: "基于光谱法研究异细交链孢菌酮酸半抗原-抗体的相互作用", 《现代食品科技》 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107255716A (en) * | 2017-06-22 | 2017-10-17 | 华南农业大学 | The monoclonal antibody and its enzyme-linked immune detection method of a kind of tenuazonic acid |
CN110470831A (en) * | 2019-07-09 | 2019-11-19 | 华南农业大学 | A kind of chemiluminescence immune analysis method and kit directly detecting tenuazonic acid based on hunchbacked source antibody |
CN110862452A (en) * | 2019-11-15 | 2020-03-06 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaA1 thereof |
CN110862452B (en) * | 2019-11-15 | 2021-05-18 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaA1 thereof |
CN110894233A (en) * | 2019-11-19 | 2020-03-20 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaC2 thereof |
CN110894232A (en) * | 2019-11-19 | 2020-03-20 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtA1 thereof |
CN110894233B (en) * | 2019-11-19 | 2021-05-18 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaC2 thereof |
CN110804092A (en) * | 2019-11-25 | 2020-02-18 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtA8 thereof |
CN110804092B (en) * | 2019-11-25 | 2021-05-18 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtA8 thereof |
CN110894234A (en) * | 2019-11-29 | 2020-03-20 | 浙江中医药大学 | Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaC5 thereof |
CN110804094A (en) * | 2019-12-03 | 2020-02-18 | 浙江中医药大学 | Monoclonal antibody for identifying alternaria tenuis and hybridoma cell strain AtD2 thereof |
CN110862970A (en) * | 2019-12-05 | 2020-03-06 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtG7 thereof |
CN110862970B (en) * | 2019-12-05 | 2022-12-20 | 浙江中医药大学 | Monoclonal antibody for identifying alternaria tenuissima and hybridoma cell strain AtG7 thereof |
CN110922479A (en) * | 2019-12-10 | 2020-03-27 | 浙江中医药大学 | Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtH9 thereof |
CN112285354A (en) * | 2020-11-13 | 2021-01-29 | 福建农林大学 | Gold nanoflower rapid detection test paper for detecting alternaria tenuifolia keto acid based on monoclonal antibody |
CN112285354B (en) * | 2020-11-13 | 2022-08-05 | 福建农林大学 | Gold nanoflower rapid detection test paper for detecting alternaria tenuifolia keto acid based on monoclonal antibody |
Also Published As
Publication number | Publication date |
---|---|
CN106591240B (en) | 2019-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106591240A (en) | Hybridoma cell strain 4F4 and antibody thereof | |
CN106701688B (en) | Hybridoma cell strain 7G11 and its antibody | |
CN104263701B (en) | Chloramphenicol universal monoclonal antibody hybridoma cell strain and application thereof | |
CN111304174A (en) | Triazolone monoclonal antibody hybridoma cell strain B11S and application thereof | |
CN105112398A (en) | Preparation of hybridoma cell, monoclonal antibody secreted by hybridoma cell and application of monoclonal antibody | |
CN105838681B (en) | One plant of anti-dexamethasone monoclonal antibody specific hybridoma cell strain C3 and its application | |
CN109868261B (en) | Preparation and application of group-selective monoclonal antibody for resisting eight triazine pesticides | |
CN110117575B (en) | Pyrimidinemonoclonal antibody hybridoma cell strain HFG and application thereof | |
CN112574957B (en) | Hybridoma cell strain secreting clomazone monoclonal antibody and application thereof | |
CN107119022A (en) | One plant of iprodione monoclonal antibody hybridoma cell strain ZXL 2 and its application | |
CN105087498B (en) | One plant of benzene thiophene cyanogen monoclonal antibody hybridoma cell strain and its application | |
CN104388392B (en) | A kind of enrofloxacin monoclonal antibody and its preparation method and application | |
CN101445558A (en) | monoclonal antibody of glycinin and application thereof | |
CN115340986B (en) | Hybridoma cell strain secreting monoclonal antibody of phorate and application thereof | |
CN111334479A (en) | Chlorhydroxypyridine monoclonal antibody hybridoma cell strain TYL and application thereof | |
CN113637642B (en) | Hybridoma cell strain secreting chlorfenapyr monoclonal antibody and application thereof | |
CN111748528B (en) | Hybridoma cell strain secreting monoclonal antibody against fipronil and metabolite thereof and application of hybridoma cell strain | |
CN107058240A (en) | One strain of hybridoma strain AB1 and its 2,4,5 trichlorophenoxyacetic acid monoclonal antibodies of generation | |
CN112266901A (en) | Azoxystrobin monoclonal antibody hybridoma cell strain and application thereof | |
CN106636006A (en) | Papaverine monoclonal antibody hybridoma cell strain YH3 and application thereof | |
CN104711230B (en) | Hybridoma DBP-4E10 and its dibutyl phthalate monoclonal antibody of generation | |
CN102146138B (en) | Monoclonal antibody of chloramphenicol and application thereof | |
CN110616194A (en) | Aconitine monoclonal antibody cell strain SJ and application thereof | |
CN106967688A (en) | One plant of anti-Lomefloxacin monoclonal antibody hybridoma cell WXX 1 of secretion and its application | |
CN110205300A (en) | Bar monoclonal antibody hybridoma cell strain, antibody of generation and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |